Clinical Trials on Non-Myeloid Malignancies in Japan
Total 869 results
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
Gilead SciencesTerminatedAcute Myeloid Leukemia | Hematologic MalignancyJapan
-
Novartis PharmaceuticalsCompletedNON-breast HER2+ MalignanciesUnited States, Italy, Korea, Republic of, Japan
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Japan
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Belgium, Italy, Korea, Republic of, Hong Kong, Israel, Finland, Spain, Japan, United States
-
PfizerCompletedAcute Myeloid LeukemiaJapan
-
AmgenTerminatedAcute Myeloid Leukemia | Multiple Myeloma | AML | Myelodysplastic Syndrome | MDS | Non-Hodgkins Lymphoma | NHLUnited States, Australia, Italy, France, Greece, Japan
-
AstraZenecaCompleted
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesJapan
-
AstraZenecaCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
Daiichi Sankyo Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
AstraZenecaCompletedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
AstraZenecaMedImmune LLCCompletedCancer | Advanced Solid MalignanciesJapan
-
AstraZenecaActive, not recruiting
-
Osaka UniversityJapan Agency for Medical Research and DevelopmentRecruitingAcute Myeloid Leukemia in RemissionJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Astellas Pharma IncCompleted
-
Keio UniversityCompletedAcute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaJapan
-
Novartis PharmaceuticalsCompleted
-
AstraZenecaTerminatedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous LeukemiaJapan
-
Mundipharma K.K.CompletedRecurrent or Refractory T/NK-cell MalignanciesJapan
-
Astellas Pharma IncCompletedLocally Advanced (Unresectable) or Metastatic Solid Tumor MalignanciesJapan
-
Kanto CML Study GroupUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Myelogenous Leukemia, Chronic, Chronic PhaseJapan
-
AstraZenecaCompletedNon-Small Cell Lung Cancer | Advanced Solid Malignancies | Neoplasms, | Metastatic Cancer,Japan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedAdvanced MalignanciesJapan
-
Daiichi Sankyo Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
CelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteJapan
-
AbbVieTerminatedCancer | Non Small Cell Lung Cancer | Acute Myeloid Leukemia (AML)United States, France, Israel, Japan, United Kingdom
-
PfizerActive, not recruitingNon-small-cell Lung Cancer | Advanced MalignanciesChina, Korea, Republic of, Taiwan, Japan, Russian Federation, Ukraine
-
OncoVerity, Inc.Janssen Pharmaceutical K.K.; argenxCompleted
-
Kanto CML Study GroupEpidemiological and Clinical Research Information NetworkCompletedChronic Myeloid LeukemiaJapan
-
Kanto CML Study GroupEpidemiological and Clinical Research Information NetworkCompleted
-
AstraZenecaCompletedAcute Myeloid LeukaemiaJapan
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
AstraZenecaMedImmune LLCCompleted
-
Boehringer IngelheimCompleted
-
Incyte CorporationTerminatedAdvanced MalignanciesUnited States, Italy, Denmark, Japan
-
Shimousa Hematology Study GroupEpidemiological and Clinical Research Information NetworkUnknown
-
Merck Sharp & Dohme LLCActive, not recruitingMature B-cell NeoplasmsJapan
-
Sumitomo Pharma Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
AstraZenecaMedImmune LLCCompletedBlood Cancer | Advanced B Cell MalignanciesJapan
-
Otsuka Pharmaceutical Co., Ltd.Korea Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid LeukemiaTaiwan, Korea, Republic of, Japan